31 Eurordis PPTs View free & download

Eurordis presentation PowerPoint PPT Presentation

Eurordis presentation - European Parliament rapporteur: MEP Miroslav Mikolasik (Slovaquia, EPP) & key ... Adoption by European Parliament at first reading in Plenary session (vote 403 ...

European Parliament rapporteur: MEP Miroslav Mikolasik (Slovaquia, EPP) & key ... Adoption by European Parliament at first reading in Plenary session (vote 403 ...

| PowerPoint PPT presentation | free to view

Support of the European Union to Research on Rare Diseases PowerPoint PPT Presentation

Support of the European Union to Research on Rare Diseases - Directorate General for Research = European public research funding body ... Reflexion workshop April 2005 (DG RTD) Received position papers (e.g. EURORDIS) ...

Directorate General for Research = European public research funding body ... Reflexion workshop April 2005 (DG RTD) Received position papers (e.g. EURORDIS) ...

| PowerPoint PPT presentation | free to view

Potential to support research PowerPoint PPT Presentation

Potential to support research - Vice Chair, Committee for Orphan Medicinal Products, COMP/EMEA. ICORD February 2005 ... Doctor Robert/Autonomous University of Barcelona Carlos III Feder; ...

Vice Chair, Committee for Orphan Medicinal Products, COMP/EMEA. ICORD February 2005 ... Doctor Robert/Autonomous University of Barcelona Carlos III Feder; ...

| PowerPoint PPT presentation | free to view

European Clinical Trial Directive (Directive 2001/20/EC) PowerPoint PPT Presentation

European Clinical Trial Directive (Directive 2001/20/EC) - European Clinical Trial Directive 1998/1999 Concerns expressed by European Patient Organisations Recommendation: ... Voor Glaxo Wellcome gelden iets andere cijfers: ...

European Clinical Trial Directive 1998/1999 Concerns expressed by European Patient Organisations Recommendation: ... Voor Glaxo Wellcome gelden iets andere cijfers: ...

| PowerPoint PPT presentation | free to view

EuropaBio Industry Hearing on Tissue Engineering and Advanced Therapies PowerPoint PPT Presentation

EuropaBio Industry Hearing on Tissue Engineering and Advanced Therapies - As the organisation representing 30 million EU patients affected by rare ... field (the AFM -French Muscular Dystrophy Association and the Italian Telethon, for ex. ...

As the organisation representing 30 million EU patients affected by rare ... field (the AFM -French Muscular Dystrophy Association and the Italian Telethon, for ex. ...

| PowerPoint PPT presentation | free to view

Akcn pln realizace Nrodn protidrogov politiky na obdob PowerPoint PPT Presentation

Akcn pln realizace Nrodn protidrogov politiky na obdob - Rare Diseases and neonatal screening. listening to the opinion of patient support groups ... 6/ RAPSODY (Rare Disease Patient Solidarity - http://www. ...

Rare Diseases and neonatal screening. listening to the opinion of patient support groups ... 6/ RAPSODY (Rare Disease Patient Solidarity - http://www. ...

| PowerPoint PPT presentation | free to view

A'E'D'A'F' Estadsticas Socios pComunidad PowerPoint PPT Presentation

A'E'D'A'F' Estadsticas Socios pComunidad - Conferencia Europea de Gen tica Humana (Amsterdam, 6-9 Mayo 2006) Conferencia EPPOSI (Madrid, 26-27 Octubre 2006) COMITES EUROPEOS CON REPRESENTANTES ...

Conferencia Europea de Gen tica Humana (Amsterdam, 6-9 Mayo 2006) Conferencia EPPOSI (Madrid, 26-27 Octubre 2006) COMITES EUROPEOS CON REPRESENTANTES ...

| PowerPoint PPT presentation | free to view

A korai fejleszt PowerPoint PPT Presentation

A korai fejleszt - A korai fejleszt s fontoss ga a Ritka Betegs gek eset n A betegszervezetek szerepe - RIROSZ. Pog ny G bor Ph.D. www.rirosz.hu Ritka s Velesz letett ...

A korai fejleszt s fontoss ga a Ritka Betegs gek eset n A betegszervezetek szerepe - RIROSZ. Pog ny G bor Ph.D. www.rirosz.hu Ritka s Velesz letett ...

| PowerPoint PPT presentation | free to view

Five years with the Orphan Drug Directive in the EU Achievements by the COMP Josep TorrentFarnell Au PowerPoint PPT Presentation

Five years with the Orphan Drug Directive in the EU Achievements by the COMP Josep TorrentFarnell Au - Five years with the Orphan Drug Directive in the EU ... SWAG. Development phase. CHMP. MA application (designated as orphan) Therapeutic indication ...

Five years with the Orphan Drug Directive in the EU ... SWAG. Development phase. CHMP. MA application (designated as orphan) Therapeutic indication ...

| PowerPoint PPT presentation | free to view

Diapositive 1 PowerPoint PPT Presentation

Diapositive 1 - Rare diseases are defined as affecting ... Primary myoblast culture from fresh human muscle biopsy ... Freezing and thawing of vital muscle biopsy for culture ...

Rare diseases are defined as affecting ... Primary myoblast culture from fresh human muscle biopsy ... Freezing and thawing of vital muscle biopsy for culture ...

| PowerPoint PPT presentation | free to view

Rare Diseases Task Force PowerPoint PPT Presentation

Rare Diseases Task Force - To propose recommendations for future action at national and European level ... Balance benefice / malefice. Positive. Improving access for EU citizens ...

To propose recommendations for future action at national and European level ... Balance benefice / malefice. Positive. Improving access for EU citizens ...

| PowerPoint PPT presentation | free to view

Diapositive 1 - Fondazione IRCCS Istituto Nazionale Carlo Besta, Milan, Italy (biobank) ... Universita' Studi Milano, UOS Malattie Neuromuscolari, Milan, Italy (biobank) ...

Fondazione IRCCS Istituto Nazionale Carlo Besta, Milan, Italy (biobank) ... Universita' Studi Milano, UOS Malattie Neuromuscolari, Milan, Italy (biobank) ...

| PowerPoint PPT presentation | free to view

Support of the European Union to Research on Rare Diseases - Support of the European Union to Research on Rare Diseases. Dr Alain Vanvossel ... Quality and safety standards for clinical gene transfer - NoE. ...

Support of the European Union to Research on Rare Diseases. Dr Alain Vanvossel ... Quality and safety standards for clinical gene transfer - NoE. ...

| PowerPoint PPT presentation | free to view

Five years with the Orphan Drug Directive in the EU Achievements by the COMP Josep TorrentFarnell Au - Five years with the Orphan Drug Directive in the EU. Achievements by the COMP ... issue for ensuring long-term sustainability by national competent authorities ...

Five years with the Orphan Drug Directive in the EU. Achievements by the COMP ... issue for ensuring long-term sustainability by national competent authorities ...

| PowerPoint PPT presentation | free to view

With the support of the Committee of the Regions PowerPoint PPT Presentation

With the support of the Committee of the Regions - Alzheimer's Disease International. Multiple Sclerosis International Federation ... Cancer Patients Association of Slovenia. American Diabetes Association ...

Alzheimer's Disease International. Multiple Sclerosis International Federation ... Cancer Patients Association of Slovenia. American Diabetes Association ...

| PowerPoint PPT presentation | free to view

A'E'D'A'F' Estadsticas Socios pComunidad - La federaci n continua avanzando (crecimiento asociados): Dic 1999 7. Ene 2000 24. Jun 2001 36 ... (European Organization of Rare Disorders) Eventos: ...

La federaci n continua avanzando (crecimiento asociados): Dic 1999 7. Ene 2000 24. Jun 2001 36 ... (European Organization of Rare Disorders) Eventos: ...

| PowerPoint PPT presentation | free to view

Diapositive 1 - Birthe Byskov Holm. The Rapsody Workshops Objectives. To engage and to develop dialogue between patients, health care professionals, ...

Birthe Byskov Holm. The Rapsody Workshops Objectives. To engage and to develop dialogue between patients, health care professionals, ...

| PowerPoint PPT presentation | free to download

Labelled reference centres : a key action of the rare diseases french action plan 20052008 PowerPoint PPT Presentation

Labelled reference centres : a key action of the rare diseases french action plan 20052008 - Care management of rare diseases is one of the 5 national strategic plans ... The EU Orphan Drugs Regulation (reglementation rule on orphan drugs) ...

Care management of rare diseases is one of the 5 national strategic plans ... The EU Orphan Drugs Regulation (reglementation rule on orphan drugs) ...

| PowerPoint PPT presentation | free to view

Enfermedades Raras PowerPoint PPT Presentation

Enfermedades Raras - 5 000 to 8 000 ER. 1 300 medicamente bien descriptas ( 2000) ... Profesionales de Rosario y Hosp. Italiano Bs As. Talleres de internet y consultas. ...

5 000 to 8 000 ER. 1 300 medicamente bien descriptas ( 2000) ... Profesionales de Rosario y Hosp. Italiano Bs As. Talleres de internet y consultas. ...

| PowerPoint PPT presentation | free to view

Towards an optimal framework for rare disease therapies in Europe PowerPoint PPT Presentation

Towards an optimal framework for rare disease therapies in Europe - Dr. Erik Tambuyzer. 2005 Industry White Paper. Plovdiv, May 2005 ... EuropaBio is the European Biotechnology Industry Association representing over ...

Dr. Erik Tambuyzer. 2005 Industry White Paper. Plovdiv, May 2005 ... EuropaBio is the European Biotechnology Industry Association representing over ...

| PowerPoint PPT presentation | free to view

Experiences of a patient organisation at the national level' PowerPoint PPT Presentation

Experiences of a patient organisation at the national level' - with erythema nodosum leprosum (ENL), a painful complication of leprosy. ... leprosy complication: the skin manifestations of erythema nodosum leprosum. ...

with erythema nodosum leprosum (ENL), a painful complication of leprosy. ... leprosy complication: the skin manifestations of erythema nodosum leprosum. ...

| PowerPoint PPT presentation | free to view

ANGIOEDEMA POR DFICIT DE C1INHIBIDOR' Ensayos clnicos en Espaa' PowerPoint PPT Presentation

ANGIOEDEMA POR DFICIT DE C1INHIBIDOR' Ensayos clnicos en Espaa' - Bloqueantes de receptores tipo II de bradicinina. C1 ... dise ado a partir de un dominio Kunitz proteico ... (Committee on Orphan Medicinal Products): 21 ...

Bloqueantes de receptores tipo II de bradicinina. C1 ... dise ado a partir de un dominio Kunitz proteico ... (Committee on Orphan Medicinal Products): 21 ...

| PowerPoint PPT presentation | free to view

The EU Experience with Orphan Drugs View of the Biotech Industry PowerPoint PPT Presentation

The EU Experience with Orphan Drugs View of the Biotech Industry - Erik Tambuyzer - Genzyme Europe. Chair Healthcare Council, EuropaBio. What is EuropaBio ? ... It aims to be a promoting force for biotechnology and makes proposals to ...

Erik Tambuyzer - Genzyme Europe. Chair Healthcare Council, EuropaBio. What is EuropaBio ? ... It aims to be a promoting force for biotechnology and makes proposals to ...

| PowerPoint PPT presentation | free to view

To a national plan strategy for Rare Diseases in Belgium PowerPoint PPT Presentation

To a national plan strategy for Rare Diseases in Belgium - To a national plan ( strategy ) for Rare Diseases. in Belgium. Herwig Jansen ... Ibuprofen is used to treat Patent ductus arteriosus in neonates (RD) ...

To a national plan ( strategy ) for Rare Diseases. in Belgium. Herwig Jansen ... Ibuprofen is used to treat Patent ductus arteriosus in neonates (RD) ...

| PowerPoint PPT presentation | free to view

Experiences of a Hungarian NGO from an EU project PowerPoint PPT Presentation

Experiences of a Hungarian NGO from an EU project - Experiences of a Hungarian NGO from an EU project ... H-1095 Budapest, Viola u. 19., Hungary, ... To help all individuals with Williams syndrome and those with similar ...

Experiences of a Hungarian NGO from an EU project ... H-1095 Budapest, Viola u. 19., Hungary, ... To help all individuals with Williams syndrome and those with similar ...

| PowerPoint PPT presentation | free to view

TERAPIA G - Title: Terapia G nica Author: Pos-Graduacao Genetica Last modified by: user Created Date: 7/24/2000 1:49:14 PM Document presentation format: Apresenta o na tela

Title: Terapia G nica Author: Pos-Graduacao Genetica Last modified by: user Created Date: 7/24/2000 1:49:14 PM Document presentation format: Apresenta o na tela

| PowerPoint PPT presentation | free to view

Kerstin Westermark PowerPoint PPT Presentation

Kerstin Westermark - 2 years if Paediatrics Investigational Plan (PIP) results included in the MA and ... PDCO Paediatric Committee - CAT Committee for Advanced Therapies ...

2 years if Paediatrics Investigational Plan (PIP) results included in the MA and ... PDCO Paediatric Committee - CAT Committee for Advanced Therapies ...

| PowerPoint PPT presentation | free to view

Red Epidemiolgica de Investigacin en Enfermedades Raras REpIER PowerPoint PPT Presentation

Red Epidemiolgica de Investigacin en Enfermedades Raras REpIER - Definici n de Enfermedad Rara en la Uni n Europea: 5 casos /10.000 habitantes y ... epidemiol gicos y terap uticos, a la vez que nos proporcione una orientaci n m s ...

Definici n de Enfermedad Rara en la Uni n Europea: 5 casos /10.000 habitantes y ... epidemiol gicos y terap uticos, a la vez que nos proporcione una orientaci n m s ...

| PowerPoint PPT presentation | free to view

DEVELOPMENTS ON THE DISSEMINATION OF THE EUROPEAN COMUNITY HEALTH INDICATORS PowerPoint PPT Presentation

DEVELOPMENTS ON THE DISSEMINATION OF THE EUROPEAN COMUNITY HEALTH INDICATORS - Key Line. An EU health information system, with indicators on health-related behaviour, ... Being developed on the basis of Public Health Programme projects and ...

Key Line. An EU health information system, with indicators on health-related behaviour, ... Being developed on the basis of Public Health Programme projects and ...

| PowerPoint PPT presentation | free to view

Red Epidemiolgica del Programa de Investigacin sobre Enfermedades Raras REPIER PowerPoint PPT Presentation

Red Epidemiolgica del Programa de Investigacin sobre Enfermedades Raras REPIER - Centro de Investigaci n sobre el S ndrome del Aceite T xico y Enfermedades Raras ... Se incentiva el desarrollo de Medicamentos Hu rfanos (Orphan Drug Act. USA, 1983) ...

Centro de Investigaci n sobre el S ndrome del Aceite T xico y Enfermedades Raras ... Se incentiva el desarrollo de Medicamentos Hu rfanos (Orphan Drug Act. USA, 1983) ...

| PowerPoint PPT presentation | free to view

Policy challenges in HTA in Europe: the impact on patient access - Policy challenges in HTA in Europe: the impact on patient access An Industry perspective Andrea Rappagliosi Vice President European Government Affairs

Policy challenges in HTA in Europe: the impact on patient access An Industry perspective Andrea Rappagliosi Vice President European Government Affairs

Eurordis PowerPoint PPT Presentations